{
    "id": 31979,
    "fullName": "BRCA2 S917_H1918del",
    "impact": "deletion",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "BRCA2 S917_H1918del results in the deletion of 1002 amino acids of the Brca2 protein from amino acids 917 to 1918 (UniProt.org). S917_H1918del has not been characterized in the scientific literature and therefore, its effect on Brca2 protein function is unknown; however, the corresponding cDNA change has been predicted to act as a reversion mutation in the context of a specific inactivating BRCA2 mutation, potentially leading to restoration of the BRCA2 open reading frame and wild-type protein function, as demonstrated by association with acquired resistance to a PARP inhibitor (PMID: 31501807).",
            "references": [
                {
                    "id": 16759,
                    "pubMedId": 31501807,
                    "title": "Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31501807"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 675,
        "geneSymbol": "BRCA2",
        "terms": [
            "BRCA2",
            "BRCC2",
            "BROVCA2",
            "FACD",
            "FAD",
            "FAD1",
            "FANCD",
            "FANCD1",
            "GLM3",
            "PNCA2",
            "XRCC11"
        ]
    },
    "variant": "S917_H1918del",
    "createDate": "01/07/2020",
    "updateDate": "01/07/2020",
    "referenceTranscriptCoordinates": {
        "id": 186305,
        "transcript": "NM_000059",
        "gDna": "chr13:g.32337104_32340109del3006",
        "cDna": "c.2749_5754del3006",
        "protein": "p.V917_H1918del1002",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19699,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with prostate cancer harboring a germline mutation, BRCA2 S1982fs, and a secondary somatic mutation, BRCA2 H1918fs, progressed while being treated with Lynparza (olaparib), and was found via ctDNA testing to have acquired 11 BRCA2 mutations that were predicted to restore the BRCA2 open reading frame, BRCA2 S1982_A1996del, S1985fs, S1989fs, Q1987fs, Q1998fs, A1981_V1986delinsI, F2000fs, S1982_K1984del, E1912fs, and S917_H1918del (PMID: 31501807).",
            "molecularProfile": {
                "id": 34436,
                "profileName": "BRCA2 S917_H1918del BRCA2 E1912fs BRCA2 H1918fs BRCA2 A1981_V1986delinsI BRCA2 S1982_A1996del BRCA2 S1982_K1984del BRCA2 S1982fs BRCA2 S1985fs BRCA2 Q1987fs BRCA2 S1989fs BRCA2 Q1998fs BRCA2 F2000fs"
            },
            "therapy": {
                "id": 837,
                "therapyName": "Olaparib",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 16759,
                    "pubMedId": 31501807,
                    "title": "Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31501807"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34434,
            "profileName": "BRCA2 S917_H1918del",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 34436,
            "profileName": "BRCA2 S917_H1918del BRCA2 E1912fs BRCA2 H1918fs BRCA2 A1981_V1986delinsI BRCA2 S1982_A1996del BRCA2 S1982_K1984del BRCA2 S1982fs BRCA2 S1985fs BRCA2 Q1987fs BRCA2 S1989fs BRCA2 Q1998fs BRCA2 F2000fs",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 186305,
            "transcript": "NM_000059",
            "gDna": "chr13:g.32337104_32340109del3006",
            "cDna": "c.2749_5754del3006",
            "protein": "p.V917_H1918del1002",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}